A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia

Journal of Pain and Symptom Management

Volumn 17, Issue 6, 1999, Pages 429-433

  Baranowski, Andrew P ^a   De Courcey, James ^b   Bonello, Edric ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Allodynia; Lidocaine; Neuropathic; Postherpetic neuralgia

Indexed keywords

LIDOCAINE;

ALLODYNIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PAIN; POSTHERPETIC NEURALGIA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; ANESTHETICS, LOCAL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; LIDOCAINE; MALE; NEURALGIA; PAIN; PAIN MEASUREMENT;

EID: 0033026669     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00032-9     Document Type: Article

References (30)

1. Straus S.E., Ostrove J.M., Inchauspe G.et al. Varicella-zoster virus infections. Ann Intern Med. 108:1988;221-237.
2. Nurmikko T. Clinical features and pathophysiologic mechanisms of postherpetic neuralgia. Neurology. 45(12 suppl 8):1995;S54-S55.
3. Ragozzino M.W., Melton L.J., Kurland L.T.et al. A population-based study of herpes zoster and its sequelae. Medicine. 61:1982;310-316.
4. Brown G.R. Herpes zoster. correlation of age, sex, distribution, neuralgia and associated disorders South Med J. 69:1976;576-578.
5. Loeser DL. Herpes zoster and postherpetic neuralgia. In: Bonica JJ, ed. The management of pain, 2nd ed. Lea and Febiger, 1990:260.
6. Tasker R.R., Dostrovsky J.O. Deafferentation and central pain. Wall P.D., Melzack R. Textbook of pain. 2nd ed:1989;161 Churchill Livingstone, New York.
7. Glazer S., Portenoy R.K. Systemic local anaesthetics in pain control. J Pain Symptom Manage. 6:1991;30-39.
8. Maciewicz R., Chung R.L., Strassman A., Hochberg F., Moskowitz M. Relief of vascular headache with intravenous lidocaine. clinical observations and a proposed mechanism Clin J Pain. 4:1988;11-16.
9. Kastrup J., Petersen P., Dejgard A., Angelo H.R., Hilsted J. Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy? Pain. 28:1987;69-75.
10. Petersen P., Kastrup J., Zeeberg I., Boysen G. Chronic pain treatment with intravenous lidocaine. Neurol Res. 8:1986;189-190.
11. Loeser J.D. Herpes zoster and postherpetic neuralgia. Pain. 25:1986;149-164.
12. Milligan N.S., Nash T.P. Treatment of post herpetic neuralgia. a review of 77 consecutive cases Pain. 23:1985;381-386.
13. Devulder J.E., Ghys L., Dhondt W., Rolly G. Neuropathic pain in cancer patients responding to subcutaneously administered lidocaine. Clin J Pain. 9:1993;220-223.
14. Brose W.G., Cousins M.J. Subcutaneous lidocaine for the treatment of neuropathic cancer pain. Pain. 45:1991;145-148.
15. Chabal C., Jacobson L., Mariano A., Chaney E., Britell C.W. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology. 76:1992;513-517.
16. Stracke H., Meyer U.E., Schumacher H.E., Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care. 15:1992;1550-1555.
17. Tanelien D.L., Maclver M.B. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology. 74:1991;934-936.
18. Chabal C., Russell L.C., Burchiel K.J. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibres originating in rat sciatic neuromas. Pain. 38:1989;333-338.
19. Woolf C.J., Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain. 23:1985;361-374.
20. Reynolds F., Beckett A.H. The determination of bupivacaine, lidocaine and mepivacaine in human blood. J Pharm Pharmacol. 20:1968;704-708.
21. Mather L.E., Cousins M.J. Local anaesthetics and their current clinical use. Drugs. 18:1979;185-205.
22. Boas R.A., Covino B.G., Shaharian A. Analgesic responses to IV lidocaine. Br J Anaesth. 54:1982;501-505.
23. Ferrante F.M., Paggioli J., Cherukuri S., Arthur G.R. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg. 82:1998;91-97.
24. Seltzer Z., Paran Y., Eisen A., Ginzburg R. Neuropathic pain in rats depends on the afferent input from nerve-end neuroma including histamine sensitive c-fibres. Neurosci Lett. 128:1991;203-206.
25. Devor M. The pathophysiology of damaged peripheral nerve. Wall P.D., Melzack R. Textbook of pain. 2nd ed:1989;63-81 Churchill Livingstone, New York.
26. Wall P.D., Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain. 17:1983;321-339.
27. Rowbotham M.C., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 41:1991;1024-1028.
28. Marchettini P., Lacerenza M., Marangoni C., Pellegata G., Sotgiu M.L., Smirne S. Lidocaine test in neuralgia. Pain. 48:1992;377-382.
29. Wallace M.S., Laitin S., Licht D., Yaksh T.L. Concentration-effect relations for intravenous lidocaine infusions in human volunteers. effects on acute sensory thresholds and capsaicin-evoked hyperpathia Anesthesiology. 86:1997;1262-1272.
30. Wallace M.S., Dyck J.B., Rossi Yaksh T.L. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain. 66:1996;69-77.